InvestorsHub Logo
Followers 32
Posts 1613
Boards Moderated 0
Alias Born 08/20/2010

Re: ATLnsider post# 590272

Tuesday, 05/02/2023 8:47:29 PM

Tuesday, May 02, 2023 8:47:29 PM

Post# of 732084
ATLnsider, does adding the activation agent poly-ICLC to DCVax-L have any downside as far adverse events since we know that DCVax has very little or no side effects as a cancer treatment which puts NWBIO as a leader in that aspect.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News